Table:
begin	end	state
1	25	signal peptide
26	27	transmembrane
28	38	non-cytoplasmic
39	59	transmembrane
60	81	cytoplasmic
82	102	transmembrane
103	120	non-cytoplasmic
121	139	transmembrane
140	148	cytoplasmic
149	168	transmembrane
169	181	non-cytoplasmic
182	205	transmembrane
206	217	cytoplasmic
218	236	transmembrane
237	270	non-cytoplasmic
271	296	transmembrane
297	308	cytoplasmic
309	327	transmembrane
328	332	non-cytoplasmic
333	355	transmembrane
356	370	cytoplasmic
371	393	transmembrane
394	395	non-cytoplasmic

Input:
>201222 FitnessBrowser__MR1:201222
MTQNKFFGSLLLIAGTTIGAGMLALPIASAGLGFGMSSMIMLIFWALMAYTALLMVEIHQ
FAPSDASLNQLARHLLGTKGQVVACIALMFLLYALCAAYIAGGGEQVHQKLTSWLGLALP
PQAGAILFTLLIGTIVGLGTHCVDLINRVLFSLKIIALILMLALLLPQVEGTHLLELPLE
QGLIVSAIPVIFTSFGFHGSIPSVVRYLGIEVKALRKIMLLGSALPLLIYLLWQLGSQGV
LSQSQLMTNQSLSGFISQLASVLHSQYLSSAISVFADLALATSFLGVSLGLFDFIAANLR
QEDNATGRSVTAAITFVPPLGFALFYPQGFITALGYAAIALVILAIFLPVSMVWVQRKQR
DKAKLPQGYRVAGGTLGLVLALLCGLAVISAQLLG

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server